SBIR/STTR Research Award

Screening Digestive Diseases with Microcantilever Arrays

Award identifier 4b8d62333e092bdbca33b7786937ae81da852ec59cf77a614a365bce38ef4aceAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$97,295

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ATOM SCIENCES, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (Applicant's Abstract): The proposed research is focused on developing a low-cost diagnostic technology to screen for digestive diseases in a clinical setting. The goal is to incorporate screening for multiple diseases into a single test. Our approach is based upon hybridization of DNA to specific peptide nucleic acid (PNA) probes attached to a microcantilever array. By measuring the bending of individual cantilevers induced by hybridization of DNA, mutant and normal alleles of a gene may be identified. The increased stability of PNA/DNA duplexes, compared to that of DNA/DNA, allows monitoring of multiple mutations with a single device. The Phase I work plan is designed to characterize PNA/DNA hybridization on microcantilever arrays by studying the G-to-A transition associated with the disease-causing Cys282Tyr mutation on the HFE gene. In Phase II, large cantilever arrays will be implemented and a prototype instrument will be built to demonstrate the commercial potential of the technology. PROPOSED COMMERCIAL APPLICATIONS: This project is aimed toward developing a low-cost technique for screening genetic diseases. The technology could be utilized for screening of inherited diseases, including the presence of hereditary digestive disease in infants. The technology could also be used for a wide variety of DNA sequence recognition applications, including screening for infectious pathogens in a hospital or as point-of-care in the physician's office, toxic chemicals or radioisotopes in industry or biowarfare, or in veterinary medicine.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.